A randomised controlled trial of a brief cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN). By Stefanopoulou et al. 2015 

Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology Practice. By Tsai et al. 2015 

"First, do no harm": Managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer. By Lomax et al. 2015

The Effect of Androgen Deprivation Therapy Before Salvage Whole-gland Cryoablation After Primary Radiation Failure in Prostate Cancer Treatment. By Li et al. 2015

Pharmacologic Androgen Deprivation and Cardiovascular Disease Risk Factors: a Systematic Review. By Romo et al. 2015 

Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. By Garcia-Albeniz et al 2015 

The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation. By Ludwig et al 2015 

Nadir Testosterone Within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Trial of Intermittent Versus Continuous ADT. By Klotz et al 2015

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial. By Zapatero et al 2015

Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy. By Lassemillante et al 2015